NEWS
PharmExec | Pharmaceutical CEO Leadership: Collaboration in Pharma – Greater Good

In this segment, members of the Pharmaceutical CEO Leadership: Collaboration in Pharma panel present the impact of society at large on collaborations. Brought to the forefront during COVID, a sense of purpose drove many companies to join forces in novel ways, simply with the common goal of creating solutions. The challenge now is how to […]

HealthBiz | Interview with Blue Water Chairman Joe Hernandez

Joe Hernandez, Chairman and Founder of Blue Water Vaccines and Blue Water Acquisition Corp is leading the way toward a universal flu vaccine and joining the SPAC brigade. But why did he work for the Danish ministry of foreign affairs?

Benzinga | EXCLUSIVE: 180 Life Sciences Identifies New Patentable CBD Analog For Drug Development For Treating Inflammation, Pain

180 Life Sciences Corp. (NASDAQ:ATNF) has identified a new synthetic CBD analog that is non-psychoactive and could have benefits in the reduction of inflammation and pain, the company announced on Wednesday. The clinical-stage biotechnology company is focused on the development of novel drugs to treat inflammatory diseases, fibrosis and pain.